Allogene Therapeutics (ALLO) Enterprise Value (2018 - 2026)
Allogene Therapeutics (ALLO) recorded Enterprise Value of $385.71 million in Q2 2026, compared with -$24.37 million a year earlier and up 16.7% from the prior quarter.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Enterprise Value (2018 - 2026) Analysis & Trends
On a TTM basis, Allogene Therapeutics' Enterprise Value came in at -$383.58 million as of Jun 30, 2026; for FY2025, it was $64.09 million, down 59.8% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of -52.7% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $159.53 million in FY2024 (+72.2%), $92.64 million in FY2023 (-76.3%), $391.2 million in FY2022 (-76.6%) and $1.67 billion in FY2021 (-38.5%).
- The Q2 2026 figure is the highest quarterly Enterprise Value since Q4 2022.
- On a year-over-year basis, Enterprise Value rose in three of the last six quarters, with growth averaging 152.1%.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 745.0% in Q1 2026, against a decline of 93.3% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $330.47 million (Q1 2026), $64.09 million (Q4 2025) and $24.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Allogene Therapeutics | 562.91 Mn | 562.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 385.71 Mn |
| Mar 31, 2026 | 330.47 Mn |
| Dec 31, 2025 | 64.09 Mn |
| Sep 30, 2025 | 24.53 Mn |
| Jun 30, 2025 | -24.37 Mn |
| Mar 31, 2025 | 39.11 Mn |
| Dec 31, 2024 | 159.53 Mn |
| Sep 30, 2024 | 295.04 Mn |
| Jun 30, 2024 | 42.46 Mn |
| Mar 31, 2024 | 377.06 Mn |
| Dec 31, 2023 | 92.64 Mn |
| Sep 30, 2023 | 67.61 Mn |
| Jun 30, 2023 | 338.69 Mn |
| Mar 31, 2023 | 248.73 Mn |
| Dec 31, 2022 | 391.20 Mn |
| Sep 30, 2022 | 1.00 Bn |
| Jun 30, 2022 | 1.15 Bn |
| Mar 31, 2022 | 858.87 Mn |
| Dec 31, 2021 | 1.67 Bn |
| Sep 30, 2021 | 3.18 Bn |
API Access
Allogene Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();